LONDON, 15 April. - (ANA) - A major UK trial exploring the possibility of a mix-and-match approach to Covid vaccination is being expanded to include the Moderna and Novavax jabs.

 

Scientists behind the Com-COV study, led by the University of Oxford, hope that combining vaccines could give “broader, longer-lasting immunity” against the coronavirus and new variants. 

 

Using different brands of vaccination for first and second doses would also give more flexibility to the vaccine rollout.  - (ANA) -

 

AB/ANA/15 April 2021 - - -